Arbutus Biopharma Corporation is a publicly traded (NASDAQ: ABUS) biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Vancouver, British Columbia and has research facilities in Warminster, Pennsylvania.
Burnaby, BC, Canada.
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Arbutus Biopharma is implementing good security practices.
Read more about the latest issues in cybersecurity
For many businesses, global third-party vendors have become an important source of strategic ...
Information Risk Management (IRM) is a form of risk mitigation through policies, procedures, and ...
Compare Arbutus Biopharma's security performance with other companies